tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Similar Stocks

101 Followers

Other Large Cap Stocks Paying Dividends

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$10.82M
-0.44
-42.31%
2 Buy
0 Hold
0 Sell
Moderate Buy
Achieve Life Sciences
$159.00M
-3.60
-11.98%
5 Buy
0 Hold
0 Sell
Strong Buy
Agile Therapeutics
$9.80M
-0.39
-51.36%
Akebia Therapeutics
$282.96M
-6.10
10.66%
2 Buy
0 Hold
0 Sell
Moderate Buy
Amgen
$177.72B
47.37
45.12%
12 Buy
8 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
IKT
Inhibikase Therapeutics
1.50
-1.10
-42.31%
ACHV
Achieve Life Sciences
4.63
-0.63
-11.98%
AGRX
Agile Therapeutics
1.43
-1.51
-51.36%
AKBA
Akebia Therapeutics
1.35
0.13
10.66%
AMGN
Amgen
331.29
103.00
45.12%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis